HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Zhang, X. Articles by Lameire, N. Search for Related Content PubMed PubMed Citation Articles by Zhang, X. Articles by Lameire, N. Related Collections Drug Monitoring and Toxicology

Speciation of Arsenic in Serum, Urine, and Dialysate of Patients on Continuous Ambulatory Peritoneal Dialysis

¹ Lab. for Anal. Chem., Inst. for Nuclear Sci., Univ. of Gent, Proeftuinstraat 86, Gent, Belgium;
² Renal Div., Dept. of Med., Univ. Hosp., DePintelaan 185, B-9000 Gent, Belgium;
^a author for correspondence: fax 32 (0)9 2646699, e-mail Cornelis@inwchem.rug.ac.be

Renal replacement therapy is currently achieved by hemodialysis (HD), hemofiltration, hemodiafiltration (HDF), continuous ambulatory peritoneal dialysis (CAPD), or renal transplantation. The concentration of trace elements in serum of patients could be influenced by these treatments. A significant increase of As concentrations in serum of patients on HD treatment has been reported (1)(2). As concentrations higher than the reference value were also observed in serum of patients on HDF [3]. Although there are several studies describing the status of trace elements in serum, plasma, and dialysate in CAPD patients [4, 5], no data on As serum concentrations of CAPD patients are available. The aim of this work is to determine total As concentrations and to speciate As species in serum, urine, and dialysate of CAPD patients.

Fourteen CAPD patients were studied. Serum, urine, and dialysate samples were collected from the University Hospital. Patients gave their informed consent before blood sampling. To decrease the influence of As intake from the diet, patients were requested to refrain from ingesting seafood during the 3 days before blood and urine collection. The reagents and apparatus for the separation and measurement of As species and for the measurement of total As have been described (6). Briefly, two types of HPLC columns were used for the separation of anionic and cationic As species: an anion exchange column (Supelcosil LC-SAX, 250 x 4.6 mm; Supelco, Bellefonte, PA) and a cation exchange column [Dionex (Sunnyvale, CA) Ionpac^® CS 10, 250 x 4 mm]. A Perkin-Elmer (Norwalk, CT) 3030 atomic absorption spectrometer was used throughout for the detection of As signals. Analysis of serum creatinine was . . . [Full Text of this Article]

Acknowledgments

References

The following articles in journals at HighWire Press have cited this article:

				X. Zhang, R. Cornelis, J. De Kimpe, L. Mees, and N. Lameire Study of arsenic–protein binding in serum of patients on continuous ambulatory peritoneal dialysis Clin. Chem., January 1, 1998; 44(1): 141 - 147. [Abstract] [Full Text] [PDF]